LSI USA

Timing emerged as one of the biggest threats to the success of build-to-buy models. Ramin Mousavi likened the model to a long engagement. “You enter into an agreement where the wedding is down the road. But the more you get to know each other, the more you find things you don’t like,” he said. “And the more successful you are, the worse it feels, because in an open market, you’d likely get a better deal.” Makower was candid: “I don’t know many build-to-buys that have actually consummated in the end.” For more details read here:  https://www.slideserve.com/James1267/why-the-clock-kills-more-deals-than-the-competition

Fluid Biomed is a medical device start-up founded by two neurosurgeons at the University of Calgary that has developed an implantable dissolving stent to divert blood flow and heal blood vessels. The desire to innovate and create positive change has always been a priority for the founders and inventors, Dr. John Wong and Dr. Alim Mitha. For more information watch this video:  https://www.lifesciencemarketresearch.com/videos/john-wong-fluid-biomed-studio-interview-lsi-usa-25

 Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid’s CTA analysis equips physicians with critical information designed to enable precision medicine. For more information watch this video: https://www.lifesciencemarketresearch.com/videos/kelly-huang-elucid-studio-interview-lsi-usa-25